Amgen (AMGN) Revenue (2009 - 2026)

Amgen has reported Revenue for 18 years, with the latest figure at $10.1 billion in Q2 2026.

• On a quarterly basis, Revenue rose 9.53% year-over-year to $10.1 billion in Q2 2026; TTM through Jun 2026 was $38.1 billion, a 9.1% increase from a year earlier, with the FY2025 full-year figure at $36.8 billion, up 9.95% from the prior year.
• Revenue was $10.1 billion for Q2 2026 at Amgen, up from $8.6 billion in the prior quarter.
• The five-year high for Revenue was $10.1 billion in Q2 2026, with the low at $459.0 million in Q4 2022.
• Average Revenue over 5 years is $7.6 billion, with a median of $8.2 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue plunged 93.3% in 2022, then soared 1685.62% in 2023.
• Over 5 years, Revenue stood at $459.0 million in 2022, then jumped by 1685.62% to $8.2 billion in 2023, then grew by 10.86% to $9.1 billion in 2024, then grew by 8.58% to $9.9 billion in 2025, then climbed by 1.91% to $10.1 billion in 2026.
• The last three Revenue figures came in at $10.1 billion (Q2 2026), $8.6 billion (Q1 2026), and $9.9 billion (Q4 2025), per Business Quant data.